Humanigen rallies 13% after chief scientific officer buys more shares Mar. 16, 2022 3:17 AM ETHGENBy: Gaurav Batavia, SA News Editor The shares of clinical-stage biotech, Humanigen (HGEN +13%) Chief Scientific Officer Dale Chappell bought 1M shares in multiple transactions for $3 worth ~$3M. Post these transactions, the officer owns 7.9M shares. On March 11, the company gained the most in nearly a year on Chief Scientific Officer insider buying. YTD, the stock lost 85.2%.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.